Diabetes Mellitus Clinical Trial
Official title:
SimCare: Physician Intervention to Improve Diabetes Care
This randomized trial will test the hypotheses that (a) a physician opinion leader intervention, (b) a "narrative process trace" physician feedback intervention, or (c) the combined intervention (a + b), are no more effective than (d) usual care in improving the clinical care of adult patients with type 2 diabetes.
This randomized trial will test the hypothesis that (a) an influential physician feedback
intervention, (b) a "narrative process trace" feedback intervention, or (c) the combined
intervention (a + b), are no more effective than (d) usual care in improving the clinical
care of adult patients with diabetes mellitus.
The unit of randomization and the unit of analysis will be primary care physicians who have
more than 10 adult patients with diabetes mellitus. The 162 physicians eligible for this
study provide care to about 6,804 adults with diagnosed diabetes at 24 primary care clinics.
The narrative process trace intervention uses automated medical record (AMR)-mounted
clinical cases to assess physicians' diabetes care decisions, with results provided as
feedback to physicians. The influential physician feedback intervention emphasizes
individualized education of physicians, which will be guided by the narrative process trace
in the combined intervention group. Usual care includes the use of a diabetes clinical
guideline, use of a diabetes patient registry that provides key clinical data for each adult
patient with diabetes, and access to clinic-based diabetes education nurses. We have shown
in previous controlled studies that the guideline, diabetes registry, and clinic-based
diabetes education nurses have failed to significantly improve diabetes care on a population
basis, thus justifying the additional, stronger interventions that now will be tested.
Dependent variables include glycemic control and cardiovascular risk reduction of all 3,360
patients cared for by the 80 study physicians. Secondary analysis will assess rates of
screening for microvascular complications. Physicians will be randomized in blocks based on
specialty, number of diabetes patients, and years of practice experience. Hierarchical data
analysis will be used to accommodate the nested data and propensity scores will be used to
correct for selection effects and missing data. Results of this experiment will advance our
theoretical understanding of physician behavior change and quantify cost and impact of three
specific intervention strategies to improve chronic disease care in the primary care
setting. The study will have substantial impact on clinical practice and policy whether the
results are positive or negative. If successful, the interventions will be easily
disseminated to other primary care practice settings.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Health Services Research
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03743779 -
Mastering Diabetes Pilot Study
|
||
| Completed |
NCT03786978 -
Pharmaceutical Care in the Reduction of Readmission Rates in Diabetes Melitus
|
N/A | |
| Completed |
NCT01804803 -
DIgital Assisted MONitoring for DiabeteS - I
|
N/A | |
| Completed |
NCT05039970 -
A Real-World Study of a Mobile Device-based Serious Health Game on Session Attendance in the National Diabetes Prevention Program
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Completed |
NCT04068272 -
Safety of Bosentan in Type II Diabetic Patients
|
Phase 1 | |
| Completed |
NCT03243383 -
Readmission Prevention Pilot Trial in Diabetes Patients
|
N/A | |
| Completed |
NCT03730480 -
User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS)
|
N/A | |
| Recruiting |
NCT02690467 -
Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm.
|
N/A | |
| Completed |
NCT02229383 -
Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus
|
Phase 3 | |
| Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
| Completed |
NCT06181721 -
Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes
|
N/A | |
| Recruiting |
NCT04489043 -
Exercise, Prediabetes and Diabetes After Renal Transplantation.
|
N/A | |
| Withdrawn |
NCT03319784 -
Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients
|
Phase 4 | |
| Completed |
NCT03542084 -
Endocrinology Auto-Triggered e-Consults
|
N/A | |
| Completed |
NCT02229396 -
Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo
|
Phase 3 | |
| Recruiting |
NCT05544266 -
Rare and Atypical Diabetes Network
|
||
| Completed |
NCT01892319 -
An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
|
||
| Completed |
NCT05031000 -
Blood Glucose Monitoring Systems: Discounter Versus Brand
|
N/A | |
| Recruiting |
NCT04039763 -
RT-CGM in Young Adults at Risk of DKA
|
N/A |